Chia S. Kow-Ming

Kuala Lumpur, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Comment on: "Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study".

Comment on: "Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study".

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: December 21, 2023

Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality.

Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: September 10, 2023

Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes.

Optimizing antidiabetic therapy: Enhancing COVID-19 outcomes for patients with type-2 diabetes.

Journal: Annales d'endocrinologie

Published: September 02, 2023

The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence.

The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence.

Journal: Cardiovascular drugs and therapy

Published: June 25, 2023

Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19.

Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19.

Journal: Angiogenesis

Published: June 22, 2023

Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment.

Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment.

Journal: Journal of psychosomatic research

Published: June 22, 2023

The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials.

The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials.

Journal: Inflammopharmacology

Published: June 09, 2023

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials.

Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials.

Journal: Inflammopharmacology

Published: April 28, 2023

How to make the best of NLRP3 inhibitors in patients with COVID-19?

How to make the best of NLRP3 inhibitors in patients with COVID-19?

Journal: European journal of clinical pharmacology

Published: April 28, 2023

RAAS inhibitors in COVID-19: They are not all the same!

RAAS inhibitors in COVID-19: They are not all the same!

Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology

Published: April 11, 2023

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19.

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19.

Journal: Inflammopharmacology

Published: March 09, 2023

Hypertension and severe COVID-19.

Hypertension and severe COVID-19.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: January 05, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026